Published in Zh Mikrobiol Epidemiol Immunobiol on July 22, 2009
Efficacy of postexposure therapy against glanders in mice. Antimicrob Agents Chemother (2015) 0.77
[The evaluation in hamadryas baboons of the possibility for the specific prevention of Ebola fever]. Vopr Virusol (1994) 1.24
[Development and study of the properties of immunoglobulin against Ebola fever]. Vopr Virusol (1996) 1.19
DNA from Drosophila melanogaster beta-heterochromatin binds specifically to nuclear lamins in vitro and the nuclear envelope in situ. Gene (1996) 1.08
[Developing principles for emergency prevention and treatment of Ebola fever]. Vopr Virusol (1997) 1.03
[The isolation of hyperimmune horse serum to the Ebola virus]. Vopr Virusol (1994) 1.02
A new transposable element in Chironomus thummi. Mol Gen Genet (1990) 0.85
[Chemotherapy for Bolivian hemorrhagic fever in experimentally infected guinea pigs]. Vopr Virusol (2009) 0.79
A molecular and cytogenetic analysis of lambda 20p7 fragment DNA from the proximal beta-heterochromatin of Drosophila melanogaster. Gene (1993) 0.78
[Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)]. Antibiot Khimioter (2008) 0.78
[Use of guinea pigs to evaluate the efficacy of a heterological immunoglobulin against Bolivian hemorrhagic fever]. Vopr Virusol (2009) 0.78
[Effectiveness of quinolones against Y. pestis]. Antibiot Khimioter (1989) 0.78
[Development and study of properties of immunoglobulins against Lassa fever]. Vopr Virusol (1997) 0.78
[In vitro efficacy of ingavirin against the Mexican pandemic subtype H1N1 of influenza A virus, strains A/California/04/2009 and A/California/07/2009]. Antibiot Khimioter (2009) 0.77
[Preparation of hyperimmune horse serum against Ebola virus]. Vopr Virusol (1995) 0.77
[Experimental assessment of the possible significance of argasid ticks in preserving the natural foci of West Nile virus infection]. Med Parazitol (Mosk) (2013) 0.77
[Toxicity estimation of unspecific medicinal antiviral agents for prophylaxis and therapy of hazard and especially hazard viral infections]. Antibiot Khimioter (2009) 0.77
[Ribavirin prophylaxis and therapy of experimental West Nile fever]. Antibiot Khimioter (2009) 0.77
[The laboratory diagnosis of an outbreak of hemorrhagic fever at Oblivskaya village, Rostov Province: proof of the etiological role of the Crimean-Congo hemorrhagic fever virus]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.77
[Design of equine serum-based Marburg virus immunoglobulin]. Vopr Virusol (2008) 0.76
[Use of guinea pigs for assessing the efficacy of vaccines against Lassa fever]. Vopr Virusol (2004) 0.76
[Temperate Legionella bacteriophage: discovery and characteristics]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.76
[Investigation of prophylactic activity of Ingavirin, a new Russian drug, against grippe A virus (H3N2)]. Antibiot Khimioter (2008) 0.76
[A trial to produce an inactivated Lassa fever vaccine]. Vopr Virusol (1994) 0.76
[Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment]. Vopr Virusol (2006) 0.76
[Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)]. Antibiot Khimioter (2010) 0.75
Development of monoclonal antibodies to highly pathogenic avian influenza H5N1 virus and their application to diagnostics, prophylaxis, and therapy. Acta Virol (2011) 0.75
[Cowpox: features of spread after cancellation of mandatory pox immunization]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Study of Ingavirin antiviral activity against Mexican pandemic influenza virus A/H1N1/2009 in vitro and in vivo]. Antibiot Khimioter (2010) 0.75
[Sensitivity and specificity of the ELISA Kit for the detection of antidobies to Junin virus]. Vopr Virusol (2015) 0.75
[Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV]. Antibiot Khimioter (2011) 0.75
[Experimental study of Grippferon antiviral activity against Mexican pandemic influenza virus A/H1N1/2009 in vitro]. Antibiot Khimioter (2011) 0.75
[Activity of antibacterial preparations against the causative agent of pseudotuberculosis in vitro]. Antibiot Khimioter (1990) 0.75
[In vitro activity of Ingavirin against influenza virus A (H3N2)]. Antibiot Khimioter (2009) 0.75
[Cytological classification of nontoxic nodular goiter]. Klin Lab Diagn (2008) 0.75
[Contribution of microbiologists of Kirov City to development of penicillin and streptomycin production processes (70 years since development of technology for submerged production of first domestic antibiotics)]. Antibiot Khimioter (2014) 0.75
[Development of the immunoenzyme test-system for detection of Ebola virus antigen]. Vopr Virusol (1996) 0.75
[Rift valley fever]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Genotyping of the Bacillus anthracis vaccine strains using the multiloci VNTR-analysis]. Mol Gen Mikrobiol Virusol (2009) 0.75
[Detection of mycotoxin T2 with different solid-phase enzyme immunoassays]. Klin Lab Diagn (2009) 0.75
[Center of special laboratory diagnostics and treatment of dangerous and exotic infectious diseases in the system of the antiepidemic protection of the territory of the Russian Federation]. Zh Mikrobiol Epidemiol Immunobiol (2002) 0.75
[Identification of clinical isolates of Burkholderia cepacia and assessment of their pathogenicity in animal experiments]. Zh Mikrobiol Epidemiol Immunobiol (2008) 0.75
[Beta-heterochromatin in Drosophila: molecular organization and function. Molecular biological analysis of a MAR/SAR DNA sequence in centromere heterochromatin of Drosophila melanogaster]. Genetika (1996) 0.75
[Methods and Means for Defense from Collateral Action of Vaccine Virus after Vaccination Against Spallpox]. Antibiot Khimioter (2015) 0.75
[Crimean-Congo hemorrhagic fever in Rostov Province: the epidemiological characteristics of an outbreak]. Zh Mikrobiol Epidemiol Immunobiol (2000) 0.75
[In vitro Ingavirin efficacy against adenoviral infection pathogen]. Antibiot Khimioter (2009) 0.75
[Experience with use of immunomodulators in treatment of tonsillitis developed at the background of preimmunization by TEOVac]. Antibiot Khimioter (2011) 0.75
[THE DEVELOPMENT OF IMMUNE ENZYME AND IMMUNE CHROMATOGRAPHIC MONOCLONAL TEST-SYSTEM FOR DETECTING TULAREMIA AGENT]. Klin Lab Diagn (2016) 0.75
[Relationship between the level of serum rearrangement of vaccinated animals and the stress of immunity to experimental plague]. Klin Lab Diagn (2007) 0.75
[Triazavirin prophylactic efficacy against influenza virus A (H5N1)]. Antibiot Khimioter (2010) 0.75
[Argentine hemorrhagic fever]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Contribution of military medical workers to development of technologies for the manufacture of the first Soviet antibiotics]. Antibiot Khimioter (1996) 0.75
[An evaluation of the possibility of obtaining an inactivated vaccine against Lassa fever]. Zh Mikrobiol Epidemiol Immunobiol (1995) 0.75
[In vitro investigation of Ingavirin efficacy against influenza B virus]. Antibiot Khimioter (2009) 0.75
[Stabilization of peroxidase conjugates used in enzyme immunoassay systems to detect Ebola and Marburg virus antigens]. Vopr Virusol (2010) 0.75
[Interferon inductor cupping of postvaccinal complications after variolation]. Antibiot Khimioter (2010) 0.75
[Estimation of possible use of interferon inductors for prevention of postvaccional reactions to TEOVac in animal models]. Antibiot Khimioter (2011) 0.75
[The nosological structure of the mortality of fetuses\infants with extremely low weight (acccording to the 2004-2008 records of the Kursk Regional Morbid Anatomy Bureau)]. Arkh Patol (2010) 0.75
[Use of antibiotics in the treatment of ulceronecrotic tonsillitis due to vaccination by tabletted smallpox vaccine]. Antibiot Khimioter (2010) 0.75
[Hantapulmonary syndrome]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Therapeutic efficacy of Triazavirin, a novel Russian chemotherapeutic, against influenza virus A (H5N1)]. Antibiot Khimioter (2011) 0.75
[Monkeypox: features of spread after cancellation of mandatory pox immunization]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Influence of cultivation temperature and Yersinia pestis fra-operon carriage on morphological features of Yersinia pseudotuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (2011) 0.75
[Development and study of immunoglobulins against Lassa fever]. Vopr Virusol (1997) 0.75
[Bolivian hemorrhagic fever]. Zh Mikrobiol Epidemiol Immunobiol (2013) 0.75
[Dynamics of chromatin position within the interphase nucleus]. Ontogenez (2000) 0.75
[Prevention and treatment of stroke complications: multidisciplinary problem]. Klin Med (Mosk) (2001) 0.75
[Biological and physico-chemical properties of Yersinia pseudotuberculosis bacterial culture having the fra-operon Yersinia pestis]. Mol Gen Mikrobiol Virusol (2008) 0.75
[Evaluation of safety of prophylactic use of immunoglobulins against viral hemorrhagic fevers from horse blood sera]. Zh Mikrobiol Epidemiol Immunobiol (2013) 0.75
[Treatment of late stages of anthracic infection]. Antibiot Khimioter (2007) 0.75
[Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome]. Antibiot Khimioter (2011) 0.75
[Investigation of triazavirin antiviral activity against influenza A virus (H5N1) in cell culture]. Antibiot Khimioter (2007) 0.75
[Study of immunogenicity and protective efficacy of a novel inactivated vaccine with chitosan against influenza A/H1N1/2009]. Zh Mikrobiol Epidemiol Immunobiol (2012) 0.75
[Fluoroquinolones: antimicrobial activity and chemotherapeutic efficacy with respect to various pathogens in highly dangerous diseases]. Antibiot Khimioter (2007) 0.75
[Estimation of in vitro Monclavit-1 virucide activity against influenza virus A (H5N1)]. Antibiot Khimioter (2010) 0.75
[The time course of changes in cell immunological parameters during administration of live dry plague vaccine]. Klin Lab Diagn (2009) 0.75